The aim of this study is to evaluate the effectiveness of caffeine versus probiotics supplementation as adjuvant therapy for preterm neonates with Bronchopulmonary dysplasia (BPD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
90
5-10 mg/kg/day IV maintenance dose given after 24 h for 2 months.
probiotics sachets supplementation orally, in the form of lyophilized lactic acid bacteria each Aluminium stick pack contains 100 mg ( Meyer et al., 2020) Probio Tec BB12-Blend 30- IF\* (SANDOZ®.) mixed with 10 ml sterile water and given by Ryle tube once daily until discharge from the unit after clinical and laboratory improvement after two months.
Tanta University
Tanta, El Gharbia, Egypt
RECRUITINGComplete blood count
Changes in blood parameters at baseline and after 2 months
Time frame: 2 months
Kidney function test
Changes in creatinine clearance at baseline and after 2 months
Time frame: 2 months
Liver function test
Changes in aspartate aminotransferase and alanine aminotransferase at baseline and after 2 months
Time frame: 2 months
Inflammatory parameter
changes in serum C-reactive protein at baseline and after 2 months
Time frame: 2 months
change in Serum Tumor necrosis factor alpha (TNF-α)
blood sample will be collected at baseline and after 2 months
Time frame: 2 months
change in serum transforming growth factor (TGF)-β.
blood sample will be collected at baseline and after 2 months
Time frame: 2 months
change in Serum superoxide dismutase (SOD)
blood sample will be collected at baseline and after 2 months
Time frame: 2 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.